1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Acute Ischemic Stroke-Pipeline Insights, 2016

Acute Ischemic Stroke-Pipeline Insights, 2016

  • November 2016
  • -
  • Delve Insight
  • -
  • 60 pages


DelveInsight’s, “ Acute Ischemic Stroke-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Acute Ischemic Stroke. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Acute Ischemic Stroke. DelveInsight’s Report also assesses the Acute Ischemic Stroke therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of Acute Ischemic Stroke
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Acute Ischemic Stroke pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Acute Ischemic Stroke and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Acute Ischemic Stroke-Pipeline Insights, 2016

Illustrative Table of contents

- Acute Ischemic Stroke Overview
- Acute Ischemic Stroke Pipeline Therapeutics
- Acute Ischemic Stroke Therapeutics under Development by Companies
- Acute Ischemic Stroke Filed and Phase III Products
- Comparative Analysis
- Acute Ischemic Stroke Phase II Products
- Comparative Analysis
- Acute Ischemic Stroke Phase I and IND Filed Products
- Comparative Analysis
- Acute Ischemic Stroke Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Acute Ischemic Stroke - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Acute Ischemic Stroke - Discontinued Products
- Acute Ischemic Stroke - Dormant Products
- Companies Involved in Therapeutics Development for Acute Ischemic Stroke
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Acute Ischemic Stroke, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Acute Ischemic Stroke Assessment by Monotherapy Products
- Acute Ischemic Stroke Assessment by Combination Products
- Acute Ischemic Stroke Assessment by Route of Administration
- Acute Ischemic Stroke Assessment by Stage and Route of Administration
- Acute Ischemic Stroke Assessment by Molecule Type
- Acute Ischemic Stroke Assessment by Stage and Molecule Type
- Acute Ischemic Stroke Therapeutics - Discontinued Products
- Acute Ischemic Stroke Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Acute Ischemic Stroke, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Acute Ischemic Stroke Assessment by Monotherapy Products
- Acute Ischemic Stroke Assessment by Combination Products
- Acute Ischemic Stroke Assessment by Route of Administration
- Acute Ischemic Stroke Assessment by Stage and Route of Administration
- Acute Ischemic Stroke Assessment by Molecule Type
- Acute Ischemic Stroke Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
North America And Europe Stroke Diagnostics Market Analysis By Technology, By Region And Segment Forecasts To 2024

North America And Europe Stroke Diagnostics Market Analysis By Technology, By Region And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The North America and Europe stroke diagnostics market is expected to reach USD 1.4 million by 2024, according to a new report by Grand View Research Inc. The stroke diagnostics market is anticipated to ...

Acute ischemic stroke (AIS)- Market Insights, Epidemiology and Market Forecast-2023

Acute ischemic stroke (AIS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts

Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • November 2016
  • by Currentpartnering

The Global In Vitro Diagnostics Partnering 2010-2016 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Diabetes Statistics in the UK

  • November 2016
    9 pages
  • Therapy  

    Statins  

    Diabetes  

  • United Kingdom  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Smoking Statistics Markets in Australia

  • November 2016
    30 pages
  • Smoking Statist...  

    Cardiovascular ...  

    Chronic Disease  

  • Australia  

    Oceania  

View report >

Related Market Segments :

Stroke

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.